The PEPS Trial – first non-digital meeting

The PEPS-trial; ‘Probiotic supplementation of extremely preterm infants in Scandinavia: A double-blind randomized control multicenter trial to reduce the risk of necrotizing enterocolitis and mortality’ had its first non-digital national meeting in Sigtuna 8-9 February 2024. Following on from a Swedish Research Council grant in early 2023 the PEPS trial is now well underway. Ten […]

Read More

New neurofilament light study

“Neurofilament light (NfL) in serum as a prognostic biomarker for brain damage and later neurodevelopment in infants with birth asphyxia” is a study in which we investigate neurofilament light (NfL) as a marker for brain damage and how it can be used in assessing prognosis for future neurodevelopment after asphyxia. A previous smaller pilot study […]

Read More